Coronavirus (COVID-19)
Featured Topics
Lead story
Other featured articles
-
Here’s How Public Health Messaging Can Help With the Next Phase of the Pandemic
As COVID-19 cases increase and officials warn of a potential new surge, confusion still bedevils our public health messaging.
Posted in -
The Economic Case for Federal Investment in COVID-19 Vaccines and Therapeutics Remains Strong
Schaeffer Initiative experts argue that there is a strong economic case for continued federal investment in COVID-19 vaccines and therapeutics.
Posted in -
Shifting the Demand for Vaccines: A Review of Strategies
Vaccines prevent millions of deaths, and yet millions of people die each year from vaccine-preventable diseases. The primary reason for these deaths is that a significant fraction of the population chooses not to vaccinate. Why don’t people vaccinate, and what can be done to increase vaccination rates besides providing free and easy access to vaccines?
Posted in -
Trends and Disparities in the Utilization of Influenza Vaccines Among Commercially Insured US Adults During the COVID-19 Pandemic
Researchers attempted tp under how COVID-19 affected influenza vaccine utilization and disparities.
Posted in
About this section
The coronavirus is impacting every aspect of our lives. Schaeffer Center experts are informing the conversation with their analysis on its impact on health, the economy, public policy, and human behavior. To get in contact with our experts, email Stephanie Hedt, Director of Communications, at hedt@usc.edu.
OUR EXPERTS ON COVID-19
MORE WORK RELATED TO COVID-19
-
Did Prioritizing Essential Workers Help to Achieve Racial/Ethnic Equity in Early COVID-19 Vaccine Distribution? The LA Pandemic Surveillance Cohort Study
Most US states and counties prioritized essential workers for early access to COVID-19 vaccines due to their heightened occupational risk. Racial/ethnic groups most impacted by COVID-19 are overrepresented among essential workers. This study estimates the effects of prioritizing essential workers on racial/ethnic equity in COVID-19 vaccination.
Categorized in -
SARS-CoV-2 Seroprevalence Among Firefighters in Los Angeles, California
Schaeffer Center researchers conducted a serological survey of firefighters in Los Angeles in October 2020.
Categorized in -
The High Cost of ‘Free’ Covid Testing
Insurance companies will inevitably pass the costs of free tests on through higher premiums or reduced benefits.
Categorized in -
Vaccines Help Reduce COVID-19 Related Anxiety and Depression
COVID-19 vaccines may offer individuals more than protection from serious illness caused by the virus— they may also reduce COVID-related anxiety and depression.
Categorized in -
The Burden of 1 Million Excess Deaths: 13.5 Million Years of Life Lost During the COVID Pandemic
Analysis of excess deaths two years into the pandemic finds adults younger than 65 years old made up 56% of life years lost.
Categorized in -
Shifting the Demand for Vaccines: A Review of Strategies
Vaccines prevent millions of deaths, and yet millions of people die each year from vaccine-preventable diseases. The primary reason for these deaths is that a significant fraction of the population chooses not to vaccinate.
Categorized in